Amgen Sets Aside $780M for Whistleblower, Kickback Suits

Biotech company Amgen, based in Thousand Oaks, Calif., has set aside $780 million to cover the costs of settling federal and state probes into its sales and marketing practices, according to a Bloomberg report.

Read more at Becker's ASC Review.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars